These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 37947598)
1. Circulating Tumour DNA as Biomarker for Colorectal Liver Metastases: A Systematic Review and Meta-Analysis. Wullaert L; van Rees JM; Martens JWM; Verheul HMW; Grünhagen DJ; Wilting SM; Verhoef C Cells; 2023 Oct; 12(21):. PubMed ID: 37947598 [TBL] [Abstract][Full Text] [Related]
2. Circulating Tumor DNA as a Minimal Residual Disease Assessment and Recurrence Risk in Patients Undergoing Curative-Intent Resection with or without Adjuvant Chemotherapy in Colorectal Cancer: A Systematic Review and Meta-Analysis. Chidharla A; Rapoport E; Agarwal K; Madala S; Linares B; Sun W; Chakrabarti S; Kasi A Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373376 [TBL] [Abstract][Full Text] [Related]
3. Dynamic monitoring of circulating tumor DNA to predict prognosis and efficacy of adjuvant chemotherapy after resection of colorectal liver metastases. Wang DS; Yang H; Liu XY; Chen ZG; Wang Y; Fong WP; Hu MT; Zheng YC; Zheng Y; Li BK; Yuan YF; Chen G; Pan ZZ; Song L; Li YH; Xu RH Theranostics; 2021; 11(14):7018-7028. PubMed ID: 34093868 [No Abstract] [Full Text] [Related]
4. Circulating tumor DNA dynamics and recurrence risk in patients undergoing curative intent resection of colorectal cancer liver metastases: A prospective cohort study. Tie J; Wang Y; Cohen J; Li L; Hong W; Christie M; Wong HL; Kosmider S; Wong R; Thomson B; Choi J; Fox A; Field K; Burge M; Shannon J; Kotasek D; Tebbutt NC; Karapetis C; Underhill C; Haydon A; Schaeffer J; Ptak J; Tomasetti C; Papadopoulos N; Kinzler KW; Vogelstein B; Gibbs P PLoS Med; 2021 May; 18(5):e1003620. PubMed ID: 33939694 [TBL] [Abstract][Full Text] [Related]
6. Circulating tumour DNA as a biomarker in resectable and irresectable stage IV colorectal cancer; a systematic review and meta-analysis. Jones RP; Pugh SA; Graham J; Primrose JN; Barriuso J Eur J Cancer; 2021 Feb; 144():368-381. PubMed ID: 33422803 [TBL] [Abstract][Full Text] [Related]
7. Postoperative circulating tumour DNA is associated with pathologic response and recurrence-free survival after resection of colorectal cancer liver metastases. Bolhuis K; van 't Erve I; Mijnals C; Delis-Van Diemen PM; Huiskens J; Komurcu A; Lopez-Yurda M; van den Broek D; Swijnenburg RJ; Meijer GA; Punt CJA; Fijneman RJA EBioMedicine; 2021 Aug; 70():103498. PubMed ID: 34333237 [TBL] [Abstract][Full Text] [Related]
8. Pre-hepatectomy dynamic circulating tumor DNA to predict pathologic response to preoperative chemotherapy and post-hepatectomy recurrence in patients with colorectal liver metastases. Liu M; Bao Q; Zhao T; Huang L; Zhang D; Wang Y; Yan X; Wang H; Jin K; Liu W; Wang K; Xing B Hepatol Int; 2024 Jun; 18(3):1029-1039. PubMed ID: 38427145 [TBL] [Abstract][Full Text] [Related]
9. Circulating tumour DNA as biomarker for rectal cancer: A systematic review and meta-analyses. van Rees JM; Wullaert L; Grüter AAJ; Derraze Y; Tanis PJ; Verheul HMW; Martens JWM; Wilting SM; Vink G; van Vugt JLA; Beije N; Verhoef C Front Oncol; 2023; 13():1083285. PubMed ID: 36793616 [TBL] [Abstract][Full Text] [Related]
10. Minimal Residual Disease using a Plasma-Only Circulating Tumor DNA Assay to Predict Recurrence of Metastatic Colorectal Cancer Following Curative Intent Treatment. Parikh AR; Chee BH; Tsai J; Rich TA; Price KS; Patel SA; Zhang L; Ibrahim F; Esquivel M; Van Seventer EE; Jarnagin JX; Raymond VM; Corvera CU; Hirose K; Nakakura EK; Corcoran RB; Van Loon K; Atreya CE Clin Cancer Res; 2024 Jul; 30(14):2964-2973. PubMed ID: 38695832 [TBL] [Abstract][Full Text] [Related]
11. Personalized circulating tumor DNA monitoring improves recurrence surveillance and management after curative resection of colorectal liver metastases: a prospective cohort study. Li Y; Xu J; Hu X; Chen Y; Liu F; Chen Y; Ma X; Dong Q; Sun L; Mo S; Zhang L; He X; Tong S; Wu H; Li W; Cai S; Zhu S; Pan Q; Peng J Int J Surg; 2024 May; 110(5):2776-2787. PubMed ID: 38445460 [TBL] [Abstract][Full Text] [Related]
12. Recurrence Prediction by Circulating Tumor DNA in the Patient with Colorectal Liver Metastases After Hepatectomy: A Prospective Biomarker Study. Liu W; Jin KM; Zhang MH; Bao Q; Liu M; Xu D; Wang K; Xing BC Ann Surg Oncol; 2023 Aug; 30(8):4916-4926. PubMed ID: 37219651 [TBL] [Abstract][Full Text] [Related]
13. Circulating tumor DNA for prognosis assessment and postoperative management after curative-intent resection of colorectal liver metastases. Reinert T; Petersen LMS; Henriksen TV; Larsen MØ; Rasmussen MH; Johansen AFB; Øgaard N; Knudsen M; Nordentoft I; Vang S; Krag SRP; Knudsen AR; Mortensen FV; Andersen CL Int J Cancer; 2022 May; 150(9):1537-1548. PubMed ID: 34994972 [TBL] [Abstract][Full Text] [Related]
14. Circulating tumour DNA-Based molecular residual disease detection in resectable cancers: a systematic review and meta-analysis. Zheng J; Qin C; Wang Q; Tian D; Chen Z EBioMedicine; 2024 May; 103():105109. PubMed ID: 38614009 [TBL] [Abstract][Full Text] [Related]
15. Prospective Study of Perioperative Circulating Tumor DNA Dynamics in Patients Undergoing Hepatectomy for Colorectal Liver Metastases. Newhook TE; Overman MJ; Chun YS; Dasari A; Tzeng CD; Cao HST; Raymond V; Parseghian C; Johnson B; Nishioka Y; Kawaguchi Y; Uppal A; Vreeland TJ; Jaimovich A; Arvide EM; Cristo JV; Wei SH; Raghav KP; Morris VK; Lee JE; Kopetz S; Vauthey JN Ann Surg; 2023 May; 277(5):813-820. PubMed ID: 35797554 [TBL] [Abstract][Full Text] [Related]
16. Impact of Preoperative Circulating Tumor DNA Status on Survival Outcomes After Hepatectomy for Resectable Colorectal Liver Metastases. Kobayashi S; Nakamura Y; Taniguchi H; Odegaard JI; Nomura S; Kojima M; Sugimoto M; Konishi M; Gotohda N; Takahashi S; Yoshino T Ann Surg Oncol; 2021 Aug; 28(8):4744-4755. PubMed ID: 33393041 [TBL] [Abstract][Full Text] [Related]
17. Association of Circulating Tumor DNA With Disease-Free Survival in Breast Cancer: A Systematic Review and Meta-analysis. Cullinane C; Fleming C; O'Leary DP; Hassan F; Kelly L; O'Sullivan MJ; Corrigan MA; Redmond HP JAMA Netw Open; 2020 Nov; 3(11):e2026921. PubMed ID: 33211112 [TBL] [Abstract][Full Text] [Related]
18. Early Circulating Tumor DNA Dynamics Predict Neoadjuvant Therapy Response and Recurrence in Colorectal Liver Metastases: A Prospective Study. Wang XY; Zhang R; Han JH; Chen SQ; Zhao FL; Chen H; Lin J; Fan J; Zhu WW; Lu L; Chen JH Ann Surg Oncol; 2023 Aug; 30(8):5252-5263. PubMed ID: 37202570 [TBL] [Abstract][Full Text] [Related]
19. Circulating Tumor DNA as a Prognostic Factor in Patients With Resectable Hepatic Metastases of Uveal Melanoma. Mariani P; Bidard FC; Rampanou A; Houy A; Servois V; Ramtohul T; Pierron G; Chevrier M; Renouf B; Lantz O; Gardrat S; Vincent-Salomon A; Roman-Roman S; Rodrigues M; Piperno-Neumann S; Cassoux N; Stern MH; Renault S Ann Surg; 2023 Oct; 278(4):e827-e834. PubMed ID: 36847256 [TBL] [Abstract][Full Text] [Related]
20. Circulation tumour DNA in predicting recurrence and prognosis in operable colorectal cancer patients: A meta-analysis. Mi J; Han X; Wang R; Ma R; Zhao D Eur J Clin Invest; 2022 Dec; 52(12):e13842. PubMed ID: 35856399 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]